CBS 2019
CBSMD教育中心
中 文

急性冠脉综合征

Abstract

Recommended Article

Interval From Initiation of Prasugrel to Coronary Angiography in Patients With Non–ST-Segment Elevation Myocardial Infarction Circulating MicroRNAs and Monocyte-Platelet Aggregate Formation in Acute Coronary Syndrome Association of Parenteral Anticoagulation Therapy With Outcomes in Chinese Patients Undergoing Percutaneous Coronary Intervention for Non-ST-Segment Elevation Acute Coronary Syndrome Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes Incidence and Outcomes of Acute Coronary Syndrome After Transcatheter Aortic Valve Replacement Early versus delayed invasive intervention in acute coronary syndromes MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy

ConsensusApril 2020

JOURNAL:JACC Article Link

Management of Acute Myocardial Infarction During the COVID-19 Pandemic

E Mahmud, HL Dauerman, FGP Welt et al. Keywords: emergency medical system; COVID-19; fibrinolysis; PCI; STEMI

Full Text PDF